Related Experiment Videos
The value of the second view in screening mammography
R M Warren1, S W Duffy, S Bashir
1Breast Screening Service, St Margaret's Hospital, Epping, Essex, UK.
The British Journal of Radiology
|February 1, 1996
Summary
Adding a second view to breast cancer screening detected more cancers, including small invasive ones, and reduced unnecessary recalls. This two-view technique improved cancer detection rates in the UK National Breast Screening Programme.
Area of Science:
- Radiology
- Oncology
- Public Health
Background:
- The UK National Breast Screening Programme (UKNBSP) aims to detect breast cancer early.
- Screening mammography techniques, including one-view and two-view imaging, are continuously evaluated for efficacy.
Purpose of the Study:
- To compare cancer detection and recall rates between one-view and two-view mammography techniques within the UKNBSP.
- To assess the impact of the two-view technique on biopsy rates and associated costs.
Main Methods:
- A prospective study involving 33,734 women screened during the prevalent round of the UKNBSP.
- Radiologists read single oblique views without knowledge of subsequent craniocaudal views to mitigate bias.
- Cancer detection rates, recall rates, and biopsy rates were compared between the one-view and two-view techniques.
Main Results:
- The two-view technique increased cancer detection from 7.6 to 8.2 per thousand women, identifying 14 additional cancers (6.5% of screen-detected cancers).
- Recall rates significantly decreased from 8.8% to 6.6% with the two-view approach (p < 0.001).
- Biopsy rates were higher in the two-view group (10.6/1000 vs. 8.6/1000, p = 0.004), capturing smaller invasive cancers.
Conclusions:
- The two-view mammography technique enhances breast cancer detection and reduces recall rates in the UKNBSP.
- While increasing biopsy rates, the additional cancers detected are often small and invasive, justifying the higher rate.
- Implementing two-view screening has resource implications but offers significant benefits for early cancer diagnosis.